Comparing the Risk of Infusion-Related Reactions and Tolerability in Patients Given Cetirizine or Diphenhydramine Prior to Ocrelizumab Infusion (PRECEPT)

MLA

Kyle Smoot, et al. “Comparing the Risk of Infusion-Related Reactions and Tolerability in Patients Given Cetirizine or Diphenhydramine Prior to Ocrelizumab Infusion (PRECEPT).” Medicina, vol. 60, no. 4, Apr. 2024, p. 659. EBSCOhost, https://doi.org/10.3390/medicina60040659.

APA

Kyle Smoot, Horia Marginean, Tiffany Gervasi-Follmar, & Chiayi Chen. (2024). Comparing the Risk of Infusion-Related Reactions and Tolerability in Patients Given Cetirizine or Diphenhydramine Prior to Ocrelizumab Infusion (PRECEPT). Medicina, 60(4), 659. https://doi.org/10.3390/medicina60040659

Chicago

Kyle Smoot, Horia Marginean, Tiffany Gervasi-Follmar, and Chiayi Chen. 2024. “Comparing the Risk of Infusion-Related Reactions and Tolerability in Patients Given Cetirizine or Diphenhydramine Prior to Ocrelizumab Infusion (PRECEPT).” Medicina 60 (4): 659. doi:10.3390/medicina60040659.